$323.39
0.28% yesterday
NYSE, Nov 20, 10:00 pm CET
ISIN
US1255091092
Symbol
CI

Cigna Stock price

$323.39
+3.16 0.99% 1M
-9.98 2.99% 6M
+23.94 7.99% YTD
+39.09 13.75% 1Y
+111.84 52.87% 3Y
+123.48 61.77% 5Y
+221.18 216.40% 10Y
NYSE, Closing price Wed, Nov 20 2024
+0.89 0.28%
ISIN
US1255091092
Symbol
CI
Sector

Key metrics

Market capitalization $89.95b
Enterprise Value $117.07b
P/E (TTM) P/E ratio 30.50
EV/FCF (TTM) EV/FCF 22.58
EV/Sales (TTM) EV/Sales 0.51
P/S ratio (TTM) P/S ratio 0.39
P/B ratio (TTM) P/B ratio 2.15
Dividend yield 1.73%
Last dividend (FY24) $5.60
Revenue growth (TTM) Revenue growth 21.01%
Revenue (TTM) Revenue $229.75b
EBIT (operating result TTM) EBIT $6.92b
Free Cash Flow (TTM) Free Cash Flow $5.18b
EPS (TTM) EPS $10.60
P/E forward 23.89
P/S forward 0.37
EV/Sales forward 0.48
Short interest 1.25%
Show more

Is Cigna a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Cigna Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a Cigna forecast:

22x Buy
88%
3x Hold
12%

Analyst Opinions

25 Analysts have issued a Cigna forecast:

Buy
88%
Hold
12%

Financial data from Cigna

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
229,747 229,747
21% 21%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 182,172 182,172
27% 27%
79%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization 2,894 2,894
4% 4%
1%
EBIT (Operating Income) EBIT 6,919 6,919
18% 18%
3%
Net Profit 3,039 3,039
43% 43%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cigna directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cigna Stock News

Neutral
CNBC
one day ago
CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional.  The complaint is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.
Positive
The Motley Fool
10 days ago
The healthcare company put merger rumors to bed.
Negative
Forbes
10 days ago
The Cigna Group confirmed “it is not pursuing a combination with Humana.”
More Cigna News

Company Profile

Cigna Corp. engages in the provision of global health services. It operates through the following segments: Health Services, Integrated Medical, International Markets, and Group Disability and Other. The Health Services segment includes pharmacy benefits management, specialty pharmacy services, clinical solutions, home delivery, and health management services. The Integrated Medical segment offers a variety of health care solutions to employers and individuals. The International Markets segment covers supplemental health, life and accident insurance products; and health care coverage in its international markets as well as health care benefits to globally mobile employees of multinational organizations. The Group Disability and Other segment represents group disability and life, corporate-owned life insurance, and run-off business consisting of reinsurance; settlement authority; and individual life insurance and annuity and retirement benefits business. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Head office United States
CEO David Cordani
Employees 72,500
Founded 1792
Website www.cigna.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today